Tag: AztraZeneca’s Vaxzevria

AztraZeneca’s Vaxzevria, highly effective after one dose vs Delta variants – Study

July 26, 2021

Vaxzevria, formerly AZD1222, was the Covid-19 vaccine co-invented by the University of Oxford and its spin-out company, Vaccitech. The vaccine has been granted a conditional marketing authorisation or emergency use in more than 80 countries across six continents. According to biopharmaceutical company […]

Continue Reading